ICYMI, this week we had stories about more adalimumab biosimilars, brepocitinib for psoriatic arthritis, sunscreen screenings for veterans, and more.
In this month’s Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses solutions for ethnic and Afro-textured hair care.
A recent study supports a degree of correlation between trough serum concentration of infliximab and clinical response to infliximab in patients with the condition.
Researchers analyzed dermatoses associated with obesity and insulin resistance in pediatric patients.
Renata Block, MMS, PA-C, spearheaded a skin cancer screening event for veterans in her hometown.
As many as 1 in 5 patients with psoriasis experience depression as a comorbidity.
Topline results for the topical sodium channel blocker are expected in 2024.
The adalimumab biosimilar will be commercially available in the US starting July 1, 2023.
The first-of-a-kind product uses a topically applied small peptide fluorescent dye and handheld imager to non-invasively detect a biomarker of early tissue changes.
In part 3 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
New research into the disease’s pathogenesis may inform future treatment options.
Cream containing epigallocatechin gallate (EGCG) or EGCG combined with L-carnitine yielded a greater anti-sebum effect.
If you weren’t able to attend SCALE 2023 or want to review the latest data, our full recap has you covered.
In this week’s Pointers with Portela, the 208SkinDoc gives his best product recommendations for Mother's Day gifts.
The autosomal recessive disorder is primarily caused by mutations in the TGM5 gene and less frequently in the CSTA gene.
While receiving checkpoint inhibitor therapy, patients with advanced melanoma benefitted from a telehealth exercise program.
Click here to answer this week's poll.
The JAK inhibitor demonstrated promising efficacy and safety.
Yuflyma will be available to US patients in July 2023.
The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.
This week's edition of the Mainstream Patient features stories about facial balancing, eyelid surgery 101, dermatologist-recommended sunscreen sticks, and more.
In this month’s Finance & Practice Management column, we illustrate the importance of developing and maintaining a budget for physicians at all stages of their careers.
Coastal regions require environmentally-protective sun protection measures and best practices.
In patients with high levels of VEGF-A and more severe psoriasis, downregulation of blood vessel area is more abrupt.